Alarming Trends in Severe Obesity in Chinese Children from 1991 to 2015

Hui Fan1, Xingyu Zhang2

  • 1Department of Preventive Medicine, North Sichuan Medical College, Nanchong, China.

Insights

Childhood overweight, obesity, and severe obesity prevalence significantly increased in China between 1991 and 2015. Severe obesity saw the largest relative increase, highlighting a growing public health concern for pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Epidemiology

Background:

  • Limited data exists on severe pediatric obesity trends in China.
  • Childhood obesity is a growing global health issue with significant long-term implications.

Purpose of the Study:

  • To examine the trends in overweight, obesity, and severe obesity among Chinese children from 1991 to 2015.
  • To assess the secular changes in pediatric weight status in China over a 25-year period.

Main Methods:

  • Utilized data from the China Health and Nutrition Survey (1991-2015) including 17,004 children aged 6-17 years.
  • Defined overweight, obesity, and severe obesity using U.S. Centers for Disease Control and Prevention (CDC) Growth Charts criteria.
  • Performed multivariate analyses to evaluate trends, controlling for age, sex, and region.

Main Results:

  • Prevalence of overweight increased from 4.6% to 21.1%, obesity from 1.4% to 10.1%, and severe obesity from 0.2% to 4.0%.
  • Relative increases were 358.7% for overweight, 621.4% for obesity, and 1900.0% for severe obesity.
  • Significant positive trends were observed for all weight categories (p < 0.001), with similar patterns across demographic subgroups.

Conclusions:

  • Childhood overweight, obesity, and particularly severe obesity have significantly increased in China from 1991 to 2015.
  • These findings underscore the urgent need for public health interventions to address the escalating pediatric obesity epidemic in China.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
166
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.2K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
189
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
123
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
764